ABCC2 and acute lymphoblastic leukemia: Reported pharmacogenomic studies of ABCC2 SNPs and vincristine induce neurotoxicity are sparse, though a predicted splice variant SNP (rs3740066) and ABCC2 haplotypes appear to be protective against low grade vincristine induced neurotoxicity in paediatric ALL, but are not associated with severe toxicity [13].